Prosecution Insights
Last updated: October 25, 2026

Berg Hill Greenleaf & Ruscitti LLP

Technology area: Biotechnology & Pharmaceuticals

25 pending office actions • 14 clients • 23 examiners • 23 art units • 0 of 25 (0%) have an AI response strategy ready

Analysis

Berg Hill Greenleaf & Ruscitti LLP has 1,021 career applications and 26 pending office actions in Biotechnology & Pharmaceuticals. The profile combines a substantial application history with an active docket in a field where prosecution often depends on precise technical and claim-focused responses.

Its resolved allowance rate is 84.38%, and the average is 3.44 office actions per allowance. These figures should be read together but not as substitutes: the rate describes resolved allowance outcomes, while the average describes examination effort for allowed matters. Practitioners can use the combination to frame portfolio expectations, then examine the relevant biological subject matter and pending-action posture in detail.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Quality Metrics (n=1021 apps, methodology: how we score firms)

84.4%
Allowance Rate
n=1021
+0.49σ
Allowance Rate (norm)
n=1021
3.4
OAs to Allowance
n=535
-0.04σ
OAs to Allow (norm)
n=535
1003 days
Time to Allowance
n=535
+15.0pp
Interview Lift
n=1021
27.9%
RCE Rate
n=1021
0.4%
Appeal Rate
n=1021

Rejection Performance (% of received rejections ultimately overcome)

60.8%
§101 Overcome
n=51
66.0%
§102 Overcome
n=253
68.9%
§103 Overcome
n=396
72.5%
§112 Overcome
n=422

Specialization & Scale

A61K, C12N, A01K
Top CPC Subclasses
15%
Top-3 CPC Share
n=1021
2
Practitioners
n=1021
510.5
Apps / Practitioner
n=1021

Portfolio Summary

25
Total Pending OAs
15
Non-Final OAs
9
Final Rejections
1
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 9 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

7
Overdue
0
Due this week
2
Due this month
0
Due in next 60 days
0
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 9 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (7)Due ≤ 30 days (2)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

15
Hard (60%)
7
Medium (28%)
3
Easy (12%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§101 + other4 (16%)
§103 only4 (16%)
§102 only2 (8%)
§112 only3 (12%)
Double-patenting + other1 (4%)
Multi-statute (no §101)11 (44%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

19
Life Sciences
76% of docket
0
Information Tech
0% of docket
1
Communications
4% of docket
1
Semiconductors
4% of docket
4
Mechanical / Eng
16% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

250 h
Manual time on pending OAs
50 h
Time saved (low, 20%)
88 h
Time saved (mid, 35%)
2.2 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
SEAMAN, D MARGARET M 2 76.6% +8.1%
KOVALENKO, MYKOLA V 2 69.6% +25.5%
DEVEAU ROSEN, JASON 1 80.0% +16.3%
WEBER, JONATHAN C 1 64.7% +28.3%
HOGE, GARY CHAPMAN 1 63.6% +22.7%
NGUYEN, TRUNG Q 1 91.0% +6.2%
SHEN, YANXIN NMN 1 84.6% +26.4%
BEZUAYEHU, SOLOMON G 1 75.7% +29.2%
SAIDHA, TEKCHAND 1 82.9% +14.0%
RILEY, JEZIA 1 83.0% +7.2%

Quick Wins (1)

Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
19290958 Novel Systems, Methods, And Compositions For The Glycosylation Of Cannabinoid Compounds DEVEAU ROSEN, JASON —

Hard Cases (15)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
17962656 Toll-Like Receptor 8 (TLR8)-Specific Antagonists and Methods of Making and Uses Thereof SEAMAN, D MARGARET M 60d overdue
17913528 PHOTO REACTOR DEVICES, SYSTEMS, AND METHODS OF USE THEREOF SEGED, NEBYATE SAMUEL 42d overdue
18787496 COMPRESSIVE ORTHOTIC DEVICE AND METHODS OF USE THEREOF RODRIQUEZ, KARI KRISTIN 15d overdue
18925427 HUMAN OSTEOPONTIN PROTEIN PRODUCTION IN PLANT SYSTEMS SHEN, YANXIN NMN 9d
17636425 Anti-C7 Antibody Or Antibody Fragment TAYLOR, LIA ELAN 19d
19020100 ORNAMENTAL DISPLAY AND METHODS OF USE THEREOF HOGE, GARY CHAPMAN —
18865231 SYSTEM AND METHOD FOR MONITORING THE OPERATING CONDITION OF ROTATING ELECTRICAL MACHINERY AND AUTOMATIC DETECTION OF MECHANICAL AND ELECTRICAL FAULTS NGUYEN, TRUNG Q —
18847671 METHODS AND COMPOSITIONS FOR DISRUPTING TAU AGGREGATES USING POLYSERINE REPEAT SEQUENCES TARGETING EXOGENOUS PROTEINS SAIDHA, TEKCHAND —

Interview Candidates (8)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
17189063 Compositions And Methods For Glycosylating Cannabinoid Compounds KOVALENKO, MYKOLA V 11d overdue
18925427 HUMAN OSTEOPONTIN PROTEIN PRODUCTION IN PLANT SYSTEMS SHEN, YANXIN NMN 9d
19290958 Novel Systems, Methods, And Compositions For The Glycosylation Of Cannabinoid Compounds DEVEAU ROSEN, JASON —
19262061 METHOD FOR MANUFACTURING AN AMMUNITION CARTRIDGE AND AMMUNITION CARTRIDGE WEBER, JONATHAN C —
19020100 ORNAMENTAL DISPLAY AND METHODS OF USE THEREOF HOGE, GARY CHAPMAN —
18854492 SYSTEM, DEVICE AND METHOD FOR PLANT IDENTIFICATION AND SPRAY CONTROL BEZUAYEHU, SOLOMON G —
18847671 METHODS AND COMPOSITIONS FOR DISRUPTING TAU AGGREGATES USING POLYSERINE REPEAT SEQUENCES TARGETING EXOGENOUS PROTEINS SAIDHA, TEKCHAND —
18430133 PRODUCTION OF CANNABINOID GLYCOSIDE COMPOUNDS IN CELL CULTURE KOVALENKO, MYKOLA V —

Client Portfolio (14 clients)

Top Art Units

Art UnitApps
16623
36411
36311
28581
16291
16631
26741
16521
16811
36511

Pending Office Actions

App #TitleClientExaminerArt UnitStatutesStatusDue inAIFiled
19290958 Novel Systems, Methods, And Compositions For The Glycosylation Of Cannabinoid Compounds Trait Biosciences, Inc. DEVEAU ROSEN, JASON 1662 §112 Non-Final OA — Pending Aug 05, 2025
19262061 METHOD FOR MANUFACTURING AN AMMUNITION CARTRIDGE AND AMMUNITION CARTRIDGE Serviço Nacional De Aprendizagem Industrial - Departamento Regional Do Rio Grande Do Sul - Senai/Rs WEBER, JONATHAN C 3641 §102 Final Rejection — Pending Jul 07, 2025
19020100 ORNAMENTAL DISPLAY AND METHODS OF USE THEREOF Balloon Innovations, Inc. HOGE, GARY CHAPMAN 3631 §102§103 Non-Final OA — Pending Jan 14, 2025
18865231 SYSTEM AND METHOD FOR MONITORING THE OPERATING CONDITION OF ROTATING ELECTRICAL MACHINERY AND AUTOMATIC DETECTION OF MECHANICAL AND ELECTRICAL FAULTS 2Neuron Solucoes Em Inteligencia Artificial Ltda NGUYEN, TRUNG Q 2858 §101§103§112 Non-Final OA — Pending Nov 12, 2024
18864247 ANTIBIOTIC COMPOSITION AND METHODS OF USE THEREOF The Regents of the University of Colorado SEAMAN, D MARGARET M 1629 §103 Non-Final OA — Pending Nov 08, 2024
18925427 HUMAN OSTEOPONTIN PROTEIN PRODUCTION IN PLANT SYSTEMS The Regents of the University of Colorado SHEN, YANXIN NMN 1663 §103§112 Non-Final OA 9d Pending Oct 24, 2024
18854492 SYSTEM, DEVICE AND METHOD FOR PLANT IDENTIFICATION AND SPRAY CONTROL Eirene Projetos E Consultoria Ltda BEZUAYEHU, SOLOMON G 2674 §103 Final Rejection — Pending Oct 04, 2024
18847671 METHODS AND COMPOSITIONS FOR DISRUPTING TAU AGGREGATES USING POLYSERINE REPEAT SEQUENCES TARGETING EXOGENOUS PROTEINS The Regents of the University of Colorado SAIDHA, TEKCHAND 1652 §102§112 Non-Final OA — Pending Sep 16, 2024
18800335 SYNTHESIS OF BACKBONE MODIFIED MORPHOLINO OLIGONUCLEOTIDES AND CHIMERAS USING PHOSPHORAMIDITE CHEMISTRY The Regents of the University of Colorado RILEY, JEZIA 1681 §102§103§112Other Non-Final OA — Pending Aug 12, 2024
18799172 BALL COLLECTION APPARATUS AND METHODS OF USE THEREOF Buchner Enterprises Inc. Dba Caddie Buddy GIOMMI, ALEXANDER PAUL 3651 §102§103 Non-Final OA — Pending Aug 09, 2024
18787496 COMPRESSIVE ORTHOTIC DEVICE AND METHODS OF USE THEREOF Quorum Orthopedics, Inc. RODRIQUEZ, KARI KRISTIN 3786 §101§102§103§112 Non-Final OA 15d overdue Pending Jul 29, 2024
18769097 PHYTOCHEMICAL INFUSED COSMETIC COMPOSITIONS AND THERAPEUTIC USES THEREOF Dewey Beauty LLC ROBERTS, LEZAH 1612 §103 Final Rejection — Pending Jul 10, 2024
18678152 WATER-SOLUBLE CANNABINOID PRODRUGS COMPOSITIONS AND METHODS OF SYNTHESIZING THE SAME Trait Biosciences, Inc. FETTEROLF, BRANDON J 1626 §102§112 Non-Final OA — Pending May 30, 2024
18430133 PRODUCTION OF CANNABINOID GLYCOSIDE COMPOUNDS IN CELL CULTURE Trait Biosciences, Inc. KOVALENKO, MYKOLA V 1662 §103§112 Non-Final OA — Pending Feb 01, 2024
18291686 COMPACT CENTRIFUGAL MIXING DEVICE AND METHODS OF USE THEREOF Flacktek Speedmixer, Inc. BHATIA, ANSHU 1774 §102§103 Non-Final OA — Pending Jan 24, 2024
18533935 CELL IMAGING AND COMPRESSION SYSTEM AND METHODS OF USE THEREOF Georgia Tech Research Corporation LYLE, SOPHIA YUAN 1796 §103§112 Final Rejection — Pending Dec 08, 2023
18364273 WATER-SOLUBLE CANNABINOID FOOD AND BEVERAGE ADDITIVE HAVING ENHANCED STABILITY Trait Biosciences, Inc. MOEHLMAN, ANDREW TERRY 1655 §102§103§112DP Non-Final OA — Pending Aug 02, 2023
18020335 ELECTROCHEMICAL MICROFLUIDIC ASSAY DEVICES Colorado State University Research Foundation MUI, CHRISTINE T 1797 §102 Final Rejection 70d overdue Pending Feb 08, 2023
17962656 Toll-Like Receptor 8 (TLR8)-Specific Antagonists and Methods of Making and Uses Thereof The Regents of the University of Colorado SEAMAN, D MARGARET M 1625 §102§112 Final Rejection 60d overdue Pending Oct 10, 2022
17913528 PHOTO REACTOR DEVICES, SYSTEMS, AND METHODS OF USE THEREOF Colorado State University Research Foundation SEGED, NEBYATE SAMUEL 1758 §103§112 Non-Final OA 42d overdue Pending Sep 22, 2022
17822992 Methods For The Identification Of UBQLN2-Mediated Amyotrophic Lateral Sclerosis (ALS) The Regents of the University of Colorado NOAKES, SUZANNE MARIE 1656 §112 Final Rejection 28d overdue Pending Aug 29, 2022
17636425 Anti-C7 Antibody Or Antibody Fragment UNIVERSITY COLLEGE CARDIFF CONSULTANTS LTD TAYLOR, LIA ELAN 1641 §101§112 Final Rejection 19d Pending Feb 18, 2022
17603276 Systems, Methods And Compositions For Recombinant In Vitro Transcription And Translation Utilizing Thermophilic Proteins Nature'S Toolbox, Inc. SMALL, KATHERINE R 1633 §103 Non-Final OA 77d overdue Pending Oct 12, 2021
17189063 Compositions And Methods For Glycosylating Cannabinoid Compounds Trait Biosciences, Inc. KOVALENKO, MYKOLA V 1662 §112 Final Rejection 11d overdue Pending Mar 01, 2021
17266502 PARN AS A BIOMARKER AND THERAPEUTIC TARGET The Regents of the University of Colorado TRAN, CHRISTINA L 1637 §101§103§112Other Non-Final OA — Pending Feb 05, 2021

Managing Berg Hill Greenleaf & Ruscitti LLP's Patent Prosecution?

IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Frequently Asked Questions

What is Berg Hill Greenleaf & Ruscitti LLP's patent allowance rate?

84.4% of resolved applications prosecuted by Berg Hill Greenleaf & Ruscitti LLP were allowed, across 1,021 applications in USPTO records.

How many office actions does Berg Hill Greenleaf & Ruscitti LLP average before allowance?

3.44 office actions per allowed application on average.

How many pending office actions does Berg Hill Greenleaf & Ruscitti LLP have?

25 pending office actions as of October 2026, for 14 clients, before 23 examiners in 23 art units.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month